Aberrant expression of GREM1 could promote tumor angiogenesis, extracellular matrix remodeling, and suppression of BMP-mediated anti-tumor signaling, thereby accelerating tumor cell proliferation and migration. This evidence concerns the gene GREM1 and neoplasm.